{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:28:54Z","timestamp":1786753734309,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cooperatio Program, research area Metabolic Diseases","award":["207037-1"],"award-info":[{"award-number":["207037-1"]}]},{"name":"Cooperatio Program, research area Metabolic Diseases","award":["207031-6"],"award-info":[{"award-number":["207031-6"]}]},{"name":"research area Health Sciences: Public Health, Hygiene and Epidemiology, Occupational Medicine","award":["207037-1"],"award-info":[{"award-number":["207037-1"]}]},{"name":"research area Health Sciences: Public Health, Hygiene and Epidemiology, Occupational Medicine","award":["207031-6"],"award-info":[{"award-number":["207031-6"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: There is little information on changes in the process and outcomes of intensive tobacco dependence treatment during the COVID-19 pandemic. The following characteristics were evaluated: interest in treatment, the number of face-to-face or telephone follow-ups, the duration of pharmacotherapy use, and the success rate. The aim of our study was to compare the number of patients who entered tobacco dependence treatment programmes and evaluate the one-year success rate in patients three years before and three years after the COVID-19 pandemic. Materials and Methods: A single-site retrospective cohort study using data from patients treated at the Centre for Tobacco Dependence in Prague, Czech Republic, between 2017 and 2022 (n = 2039) was performed. The one-year abstinence rate was validated by measuring carbon monoxide in exhaled air (6 ppm cut-off). Patients were divided into two groups: the group for which treatment was initiated in 2017\u20132019 (i.e., before the COVID-19 pandemic, BC; n= 1221) and the group for which treatment was initiated in 2020\u20132022 (i.e., during the COVID-19 pandemic, DC; n = 818). Results: No significant differences in the success rate of tobacco dependence treatment were found between the two groups (BC group, 40.5% (494\/1221) vs. DC group, 42.2% (345\/818)) (\u03c72 (1, N = 2.039) = 0.6, p = 0.440). Furthermore, differences were not found in sex, education level, age at first cigarette, the duration of pharmacotherapy use, or the number of in-person visits. In contrast, there was an increase in the number of telephone contacts between the groups (18.7% (SD = 17.5%) vs. 32.9% (SD = 18.2%), p &lt; 0.001). Conclusions: The number of patients who started treatment during the COVID-19 pandemic decreased by one-third compared to that during the 3-year period before the pandemic. The overall treatment success rate did not change significantly even with the increase in the number of telephone visits with the therapist.<\/jats:p>","DOI":"10.3390\/medicina60091459","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T05:02:28Z","timestamp":1725598948000},"page":"1459","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Changes in the Success and Characteristics of Tobacco Dependence Treatment before and during the COVID-19 Pandemic: Clinical Sample Comparisons"],"prefix":"10.3390","volume":"60","author":[{"given":"Lenka","family":"Stepankova","sequence":"first","affiliation":[{"name":"Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Zvolska","sequence":"additional","affiliation":[{"name":"Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pankova","sequence":"additional","affiliation":[{"name":"Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"},{"name":"Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5102-9354","authenticated-orcid":false,"given":"Jakub","family":"Rafl","sequence":"additional","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-5932","authenticated-orcid":false,"given":"Gleb","family":"Donin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-0877","authenticated-orcid":false,"given":"Ales","family":"Tichopad","sequence":"additional","affiliation":[{"name":"Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kralikova","sequence":"additional","affiliation":[{"name":"Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"},{"name":"Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"ref_1","unstructured":"(2008). Treating Tobacco Use and Dependence: 2008 Update U.S. Public Health Service Clinical Practice Guideline Executive Summary. Respir. Care, 53, 1217\u20131222."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ofori, S., Lu, C., Olasupo, O.O., Dennis, B.B., Fairbairn, N., Devereaux, P.J., and Mbuagbaw, L. (2023). Cytisine for Smoking Cessation: A Systematic Review and Meta-Analysis. Drug Alcohol Depend., 251.","DOI":"10.1016\/j.drugalcdep.2023.110936"},{"key":"ref_3","first-page":"3","article-title":"Doporu\u010den\u00ed pro L\u00e9\u010dbu Z\u00e1vislosti Na Tab\u00e1ku","volume":"61","year":"2015","journal-title":"Vnit\u0159. L\u00e9ka\u0159stv\u00ed"},{"key":"ref_4","unstructured":"(2024, May 17). Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence: Tools for Public Health. Available online: https:\/\/www.who.int\/publications-detail-redirect\/policy-recommendations-for-smoking-cessation-and-treatment-of-tobacco-dependence-tools-for-public-health."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18332\/tid\/125580","article-title":"The Double-Edged Relationship between COVID-19 Stress and Smoking: Implications for Smoking Cessation","volume":"18","author":"Bommele","year":"2020","journal-title":"Tob. Induc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-020-02399-5","article-title":"Eating Habits and Lifestyle Changes during COVID-19 Lockdown: An Italian Survey","volume":"18","author":"Gualtieri","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ntr\/ntaa072","article-title":"Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19","volume":"22","author":"Klemperer","year":"2020","journal-title":"Nicotine Tob. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000515438","article-title":"The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany","volume":"27","author":"Koopmann","year":"2021","journal-title":"Eur. Addict. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sidor, A., and Rzymski, P. (2020). Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients, 12.","DOI":"10.3390\/nu12061657"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14659891.2021.1941344","article-title":"Substance Use during the COVID-19 Pandemic in Greece","volume":"27","author":"Rantis","year":"2021","journal-title":"J. Subst. Use"},{"key":"ref_11","first-page":"17","article-title":"Substance Use during the COVID-19 Pandemic: What Is Really Happening?","volume":"33","author":"Mellos","year":"2022","journal-title":"Psychiatr. Psychiatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18332\/tpc\/126976","article-title":"The psychosocial impact of the COVID-19 pandemic on changes in smoking behavior: Evidence from a nationwide survey in the UK","volume":"6","author":"Chen","year":"2020","journal-title":"Tob. Prev. Cessat."},{"key":"ref_13","unstructured":"Cs\u00e9my, L., Dvo\u0159\u00e1kov\u00e1, Z., Fialov\u00e1, A., Kodl, M., Mal\u00fd, M., and Sk\u00fdvov\u00e1, M. (2024, August 15). N\u00e1rodn\u00ed V\u00fdzkum U\u017e\u00edv\u00e1n\u00ed Tab\u00e1ku a Alkoholu v \u010cesk\u00e9 Republice 2021 (NAUTA). St\u00e1tn\u00ed Zdravotn\u00ed \u00dastav, Praha. Available online: https:\/\/archiv.szu.cz\/uploads\/documents\/szu\/aktual\/NAUTA_2021.pdf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/ADM.0000000000000685","article-title":"Innovation during COVID-19: Improving Addiction Treatment Access","volume":"14","author":"Samuels","year":"2020","journal-title":"J. Addict. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ornell, F., Moura, H.F., Scherer, J.N., Pechansky, F., Kessler, F.H.P., and von Diemen, L. (2020). The COVID-19 Pandemic and Its Impact on Substance Use: Implications for Prevention and Treatment. Psychiatry Res., 289.","DOI":"10.1016\/j.psychres.2020.113096"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13011-022-00446-6","article-title":"COVID 19-Impact on Substance Use Treatment Utilization and Provision in South Africa","volume":"17","author":"Harker","year":"2022","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/add.15295","article-title":"Association of the COVID-19 Lockdown with Smoking, Drinking and Attempts to Quit in England: An Analysis of 2019\u201320 Data","volume":"116","author":"Jackson","year":"2021","journal-title":"Addiction"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Meacham, M.C., Vogel, E.A., Thrul, J., Ramo, D.E., and Satre, D.D. (2021). Addressing Cigarette Smoking Cessation Treatment Challenges during the COVID-19 Pandemic with Social Media. J. Subst. Abuse Treat., 129.","DOI":"10.1016\/j.jsat.2021.108379"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.37765\/ajmc.2021.88573","article-title":"Differences in the Use of Telephone and Video Telemedicine Visits during the COVID-19 Pandemic","volume":"27","author":"Jorge","year":"2021","journal-title":"Am. J. Manag. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/M20-3026","article-title":"Reduced In-Person and Increased Telehealth Outpatient Visits during the COVID-19 Pandemic","volume":"174","author":"Baum","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1176\/appi.ps.202100088","article-title":"Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights during the COVID-19 Pandemic","volume":"73","author":"Mark","year":"2022","journal-title":"Psychiatr. Serv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/add.15903","article-title":"Prevalence of Use and Real-World Effectiveness of Smoking Cessation Aids during the COVID-19 Pandemic: A Representative Study of Smokers in England","volume":"117","author":"Jackson","year":"2022","journal-title":"Addiction"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10900-020-00880-2","article-title":"The Effect of the COVID-19 Pandemic on Smoking Cessation Success","volume":"46","year":"2021","journal-title":"J. Community Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Veldhuizen, S., Selby, P., Wong, B., and Zawertailo, L. (2021). Effect of COVID-19 on Smoking Cessation Outcomes in a Large Primary Care Treatment Programme: An Observational Study. BMJ Open, 11.","DOI":"10.1136\/bmjopen-2021-053075"},{"key":"ref_25","first-page":"431","article-title":"Impacts of the Covid-19 Pandemic on Smoking Cessation Success","volume":"23","author":"Turan","year":"2023","journal-title":"Afr. Health Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2021.05.006","article-title":"Impact of COVID-19 Lockdown on Individuals under Treatment for Substance Use Disorders: Risk Factors for Adverse Mental Health Outcomes","volume":"139","author":"Blithikioti","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome Criteria in Smoking Cessation Trials: Proposal for a Common Standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction"},{"key":"ref_28","first-page":"33","article-title":"Tobacco Dependence Treatment Guidelines","volume":"161","year":"2022","journal-title":"Cas. Lek. Cesk."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/ntr\/ntab073","article-title":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)","volume":"23","author":"Nides","year":"2021","journal-title":"Nicotine Tob. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/add.15175","article-title":"Comparison between Success Rates for Smokers Re-Treated by a Smokers\u2019 Clinic and Success Rates for Smokers Treated for the First Time","volume":"116","author":"Stepankova","year":"2021","journal-title":"Addiction"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hajkova, D., Sandora, J., \u017d\u00eddkov\u00e1, R., Malinakova, K., and Novak, L. (2023). Effects of the COVID-19 pandemic on Czech citizens: How do depression and anxiety symptoms influence cognitive, behavioral, and emotional changes?. Front. Psychol., 14.","DOI":"10.3389\/fpsyg.2023.1204824"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/pubmed\/fdaa106","article-title":"Increased generalized anxiety, depression and distress during the COVID-19 pandemic: A cross-sectional study in Germany","volume":"42","author":"Teufel","year":"2020","journal-title":"J. Public Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jad.2020.10.036","article-title":"The COVID-19 pandemic and serious psychological consequences in Bangladesh: A population-based nationwide study","volume":"279","author":"Mamun","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Midorikawa, H., Aiba, M., Lebowitz, A., Taguchi, T., Shiratori, Y., Ogawa, T., Takahashi, A., Takahashi, S., Nemoto, K., and Arai, T. (2021). Confirming validity of the Fear of COVID-19 Scale in Japanese with a nationwide large-scale sample. PLoS ONE, 16.","DOI":"10.1037\/t79211-000"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Remr, J. (2023). Psychometric Performance of the Fear of COVID-19 Scale (FCV-19S) and Its Validation in Czechia. Sustainability, 15.","DOI":"10.3390\/su15118990"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s11469-020-00428-4","article-title":"Fear of COVID-19 in Romania: Validation of the Romanian Version of the Fear of COVID-19 Scale Using Graded Response Model Analysis","volume":"20","year":"2022","journal-title":"Int. J. Ment. Health Addict."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11469-020-00343-8","article-title":"Gender and Fear of COVID-19 in a Cuban Population Sample","volume":"20","year":"2022","journal-title":"Int. J. Ment. Health Addict."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nomura, A., Tanigawa, T., Muto, T., Oga, T., Fukushima, Y., Kiyosue, A., Miyazaki, M., Hida, E., and Satake, K. (2019). Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial. J. Med. Internet Res., 21.","DOI":"10.2196\/preprints.13520"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2196\/jmir.3975","article-title":"Comparative and Cost Effectiveness of Telemedicine versus Telephone Counseling for Smoking Cessation","volume":"17","author":"Richter","year":"2015","journal-title":"J. Med. Internet Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E957","DOI":"10.9778\/cmajo.20210053","article-title":"Changes in the Reach of a Smoking Cessation Program in Ontario, Canada, during the COVID-19 Pandemic: A Cross-Sectional Study","volume":"9","author":"Minian","year":"2021","journal-title":"CMAJ Open"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/ntr\/ntac103","article-title":"Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation Program","volume":"24","author":"Veldhuizen","year":"2022","journal-title":"Nicotine Tob. Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bandi, P., Asare, S., Majmundar, A., Xue, Z., Han, X., Westmaas, J.L., Nargis, N., and Jemal, A. (2022). Changes in Smoking Cessation-Related Behaviors among US Adults during the COVID-19 Pandemic. JAMA Netw. Open, 5.","DOI":"10.1001\/jamanetworkopen.2022.25149"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psc.2021.11.006","article-title":"Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments","volume":"45","author":"Melamed","year":"2022","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_44","first-page":"44","article-title":"Intenzivn\u00ed l\u00e9\u010dba z\u00e1vislosti na tab\u00e1ku v \u010cesku v letech 2010\u20132022","volume":"163","year":"2024","journal-title":"\u010casopis L\u00e9ka\u0159\u016f \u010cesk\u00fdch"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/9\/1459\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:49:37Z","timestamp":1760111377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/9\/1459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["medicina60091459"],"URL":"https:\/\/doi.org\/10.3390\/medicina60091459","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}